An Introduction to Retina/Vitreous
Retinal diseases are a leading cause of vision loss and blindness, but advances in imaging and treatment have improved patient outcomes over recent years. The introduction of OCT-A has had a big impact on the diagnosis and management of conditions such as diabetic macular oedema (DMO) and diabetic retinopathy. The treatment landscape of these conditions was revolutionized following the introduction of anti-VEGF therapies, and research into longer-lasting, multi-targeted treatments is currently underway.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
Roxane Hillier, EURETINA 2021: Retinal Recovery after Pneumatic Retinopexy
We were delighted to catch up with Roxane Hillier (Newcastle Eye Centre, Newcastle, UK), who gave us her insights on the impact of pneumatic retinopexy (PnR) on vision-related quality of life, and retinal recovery following PnR. Questions What is the impact of pneumatic retinopexy (PnR) on vision-related quality of life? (00:13) What is known about […]
Roxane Hillier, EURETINA 2021: Pneumatic Retinopexy for the Management of Rhegmatogenous Retinal Detachment
It was wonderful to speak with Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) about the advantages of pneumatic retinopexy compared with pars plana vitrectomy for the management of rhegmatogenous retinal detachment. Questions Why has the optimal surgical technique for the treatment of rhegmatogenous retinal detachment (RRD) been controversial? (00:12) What are the advantages of pneumatic […]
Paisan Ruamviboonsuk, EURETINA 2021: Artificial Intelligence Platforms for Diagnosis and Screening for Polypoidal Choroidal Vasculopathy
We enjoyed catching up with Paisan Ruamviboonsuk (Rajavithi Hospital, Bangkok, Thailand) about the clinical evidence supporting the use of artificial intelligence platforms in diagnosis and screening for polypoidal choroidal vasculopathy, and the unanswered questions that remain. Questions What clinical evidence supports the use of artificial intelligence platforms in the diagnosis and screening for polypoidal choroidal […]
Paisan Ruamviboonsuk, EURETINA 2021: Artificial Intelligence in Ophthalmology
It was a pleasure to speak with Paisan Ruamviboonsuk (Rajavithi Hospital, Bangkok, Thailand) about his views on artificial intelligence in ophthalmology, specifically for diagnosis and screening for polypoidal choroidal vasculopathy. Questions Could you give us a brief overview of your research in artificial intelligence (AI) in ophthalmology? (00:18) What is the potential of AI in […]
Gemmy Cheung, EURETINA 2021: New Insight on Polypoidal Choroidal Vasculopathy
We were delighted to speak with Gemmy Cheung (Singapore National Eye Center, Singapore) about recent research in the pathogenesis of polypoidal choroidal vasculopathy, and the gaps in knowledge that remain. Questions Could you give us a brief overview of the epidemiology and clinical features of polypoidal choroidal vasculopathy (PCV)? (00:10) What has recent research taught […]
The Safety of Medical Devices Used During Intraocular Surgery
US Ophthalmic Review. 2021;13(2):73–5 DOI: https://doi.org/10.17925/USOR.2020.13.2.73
Since 2013, a series of acute ocular toxicity events have occurred, causing hundreds of cases of irreversible blindness. This has prompted the questioning of measures adopted by health regulatory bodies to approve the commercialization of certain products.1 The greatest problem is the use of perfluorocarbon liquids; however, cases of toxicity have occurred with other intraocular substances […]
J Fernando Arevalo, AAO 2020 – Intravitreal Anti-VEGF Injections for Exudative Retinal Arterial Macroaneurysms
It was a pleasure to catch up with our valued Editorial Board member, J Fernando Arevalo (Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA), who gave his insights on his topic at the retina subspecialty day at AAO 2020, intravitreal anti-VEGF injections for exudative retinal arterial macroaneurysms. Questions Could you give […]
Tommaso Rossi, EURETINA 2020 – Novel Instrument for Internal Limiting Membrane
We were delighted to catch up with Prof. Tommaso Rossi, who talked us through his presentation at EURETINA 2020 concerning a novel instrument for internal limiting membrane, amniotic and retinal flap manipulation. Questions What is the rationale for the use of amniotic membrane grafts in vitreoretinal surgery, and in what ophthalmic indications are they used? […]
Peter Stalmans, EURETINA 2020 – End-stage Retinitis Pigmentosa Patients Implanted with 3D–neural Interface Retinal Prosthesis
Prof. Peter Stalmans (University Hospitals, Leuven, Belgium) talked us through his presentation at EURETINA on first reported clinical results from end-stage retinitis pigmentosa patients implanted with an innovative 3D neural interface retinal prosthesis. Questions Could you give us an overview of advances in retinal prosthesis approaches in the treatment of advanced retinitis pigmentosa […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!